Proteomic analysis of glioma biopsies shows consistency with glioma grading
M. Amer,
J.-L. Boulay,
M.-F. Ritz,
F.S. Halbeisen,
A. Schmidt,
K. Buczak,
G. Hutter,
S. Leu
Affiliations
M. Amer
University Hospital of Basel, Brain Tumor Immuno-Therapy and Biology Laboratory, Department of Biomedicine, Basel, Switzerland
J.-L. Boulay
University Hospital of Basel, Brain Tumor Immuno-Therapy and Biology Laboratory, Department of Biomedicine, Basel, Switzerland
M.-F. Ritz
University Hospital of Basel, Brain Tumor Immuno-Therapy and Biology Laboratory, Department of Biomedicine, Basel, Switzerland
F.S. Halbeisen
University Hospital of Basel, Basel Institute for Clinical Epidemiology and Biostatistics, Basel, Switzerland
A. Schmidt
Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland
K. Buczak
Proteomics Core Facility, Biozentrum, University of Basel, Basel, Switzerland
G. Hutter
University Hospital of Basel, Brain Tumor Immuno-Therapy and Biology Laboratory, Department of Biomedicine, Basel, Switzerland; University Hospital of Basel, Department of Neurosurgery, Basel, Switzerland
S. Leu
University Hospital of Basel, Department of Neurosurgery, Basel, Switzerland; University Hospital of Basel, Brain Tumor Immuno-Therapy and Biology Laboratory, Department of Biomedicine, Basel, Switzerland
